383 related articles for article (PubMed ID: 26558423)
41. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.
Xu X; Zhang L; Wang Y; Zhang Q; Zhang L; Sun B; Zhang Y
Int J Clin Exp Pathol; 2013; 6(4):788-94. PubMed ID: 23573328
[TBL] [Abstract][Full Text] [Related]
42. [Double-Hit Follicular Lymphoma with BCL2 and MYC Translocations].
Horiuchi M; Fuseya H; Tsutsumi M; Hayashi Y; Hagihara K; Kanashima H; Nakao T; Fukushima Y; Inoue T; Yamane T
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1135-8. PubMed ID: 27628560
[TBL] [Abstract][Full Text] [Related]
43. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Petrich AM; Nabhan C; Smith SM
Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
[TBL] [Abstract][Full Text] [Related]
44. BCL2 and MYC dual-hit lymphoma/leukemia.
Tomita N
J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
[TBL] [Abstract][Full Text] [Related]
45. "Triple hit" lymphomas: A retrospective cytology case series of an uncommon high grade B-cell malignancy with C-MYC, BCL-2 and BCL-6 rearrangements.
Eldessouki T; Hanley K; Hamadeh F; Oshilaja OO; Sturgis CD
Diagn Cytopathol; 2018 Sep; 46(9):807-811. PubMed ID: 30043475
[TBL] [Abstract][Full Text] [Related]
46. [Clinical features in DLBCL and translocation BCL2/c-MYC "double hit" lymphoma].
Škunca Ž; Domimis M; Plninc-Peraica A; Jakšić B
Acta Med Croatica; 2014 Jun; 68(3):299-305. PubMed ID: 26016222
[TBL] [Abstract][Full Text] [Related]
47. MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Perry AM; Alvarado-Bernal Y; Laurini JA; Smith LM; Slack GW; Tan KL; Sehn LH; Fu K; Aoun P; Greiner TC; Chan WC; Bierman PJ; Bociek RG; Armitage JO; Vose JM; Gascoyne RD; Weisenburger DD
Br J Haematol; 2014 May; 165(3):382-91. PubMed ID: 24506200
[TBL] [Abstract][Full Text] [Related]
48. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
[TBL] [Abstract][Full Text] [Related]
50. [Refractory double-hit lymphoma/leukemia in childhood mimicking B-precursor acute lymphoblastic leukemia at initial presentation].
Uemura S; Hasegawa D; Yokoi T; Nino N; Tahara T; Tamura A; Saito A; Kozaki A; Kishimoto K; Ishida T; Kawasaki K; Yamamoto N; Mori T; Nishimura N; Kosaka Y
Rinsho Ketsueki; 2017; 58(2):143-149. PubMed ID: 28321092
[TBL] [Abstract][Full Text] [Related]
51. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with
Uchida A; Isobe Y; Uemura Y; Nishio Y; Sakai H; Kato M; Otsubo K; Hoshikawa M; Takagi M; Miura I
BMC Clin Pathol; 2017; 17():21. PubMed ID: 29151814
[TBL] [Abstract][Full Text] [Related]
52. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
Knezevich S; Ludkovski O; Salski C; Lestou V; Chhanabhai M; Lam W; Klasa R; Connors JM; Dyer MJ; Gascoyne RD; Horsman DE
Leukemia; 2005 Apr; 19(4):659-63. PubMed ID: 15716988
[TBL] [Abstract][Full Text] [Related]
53. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.
Horn H; Ziepert M; Wartenberg M; Staiger AM; Barth TF; Bernd HW; Feller AC; Klapper W; Stuhlmann-Laeisz C; Hummel M; Stein H; Lenze D; Hartmann S; Hansmann ML; Möller P; Cogliatti S; Pfreundschuh M; Trümper L; Loeffler M; Glass B; Schmitz N; Ott G; Rosenwald A;
Leukemia; 2015 Jul; 29(7):1564-70. PubMed ID: 25687653
[TBL] [Abstract][Full Text] [Related]
54. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
[TBL] [Abstract][Full Text] [Related]
55. Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma.
Fiskvik I; Beiske K; Delabie J; Yri O; Spetalen S; Karjalainen-Lindsberg ML; Leppä S; Liestøl K; Smeland EB; Holte H
Leuk Lymphoma; 2015 Jun; 56(6):1742-9. PubMed ID: 25284491
[TBL] [Abstract][Full Text] [Related]
56. Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation - how to treat?
Zhang C; Amos Burke GA
Leuk Lymphoma; 2018 Aug; 59(8):1807-1813. PubMed ID: 29022749
[TBL] [Abstract][Full Text] [Related]
57. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
58. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
[TBL] [Abstract][Full Text] [Related]
59. The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia.
Lu XY; Harris CP; Cooley L; Margolin J; Steuber PC; Sheldon M; Rao PH; Lau CC
Leukemia; 2002 Nov; 16(11):2222-7. PubMed ID: 12399965
[TBL] [Abstract][Full Text] [Related]
60. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
